| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.36 | 0.002 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.098 | 0.002 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |